Skip to main content

Advertisement

SpringerLink
Log in

T-cell lymphoma associated with dupilumab

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Silverberg JI, Simpson EL, Ardeleanu M, Thaçi D, Barbarot S, Bagel J, Chen Z, Eckert L, Chao J, Korotzer A, Rizova E, Rossi AB, Lu Y, Graham NMH, Hultsch T, Pirozzi G, Akinlade B (2019) Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator’s Global Assessment: a pooled analysis of data from two phase III trials. Br J Dermatol 181(1):80–87. https://doi.org/10.1111/bjd.17791

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Espinosa ML, Nguyen MT, Aguirre AS, Martinez-Escala ME, Kim J, Walker CJ, Pontes DS, Silverberg JI, Choi J, Pro B, Pincus LB, Guitart J, Zhou XA (2020) Progression of cutaneous T-cell lymphoma after dupilumab: case review of 7 patients. J Am Acad Dermatol 83(1):197–199. https://doi.org/10.1016/j.jaad.2020.03.050

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Russomanno K, Carver DeKlotz CM (2021) Acceleration of cutaneous T-cell lymphoma following dupilumab administration. JAAD Case Rep 8:83–85. https://doi.org/10.1016/j.jdcr.2020.12.010

    Article  PubMed  Google Scholar 

  4. Newsom M, Hrin ML, Hamid RN, Strowd LC, Ahn C, Jorizzo JL, Feldman SR (2021) Two cases of mycosis fungoides diagnosed after treatment non-response to dupilumab. Dermatol Online J 27(1). https://doi.org/10.5070/d3271052041

  5. Miyashiro D, Vivarelli AG, Gonçalves F, Cury-Martins J, Sanches JA (2020) Progression of mycosis fungoides after treatment with dupilumab: a case report. Dermatol Ther 33(6):e13880. https://doi.org/10.1111/dth.13880

    Article  PubMed  Google Scholar 

  6. Claire Hollins L, Wirth P, Fulchiero GJ, Foulke GT (2020) Long-standing dermatitis treated with dupilumab with subsequent progression to cutaneous T-cell lymphoma. Cutis 106(2):E8–E11. https://doi.org/10.12788/cutis.0074

    Article  PubMed  Google Scholar 

  7. Amagai, M., Ozawa, M., Amagai, R., Ohuchi, K., Muto, Y., Kambayashi, Y., Aiba, S., & Fujimura, T. (2022). Nodal anaplastic large cell lymphoma with lymphomatoid papulosis following treatment of initially presumed atopic dermatitis with dupilumab: a case report. In Dermatologic Therapy 35, 3. John Wiley and Sons Inc. https://doi.org/10.1111/dth.15290

    Chapter  Google Scholar 

  8. Du-Thanh A, Gustave V, Dereure O (2021) Lethal anaplastic large-cell lymphoma occurring in a patient treated with dupilumab. JAAD Case Rep 18:4–7. https://doi.org/10.1016/j.jdcr.2021.09.020

    Article  PubMed  PubMed Central  Google Scholar 

  9. Ahatov R, Good AJ, Joo M, Tipton S, Goodwin B, Kelly B (2022) A rare case of aggressive cytotoxic T-cell lymphoma in a patient on dupilumab. JAAD Case Rep 24:112–114. https://doi.org/10.1016/j.jdcr.2022.04.023

    Article  PubMed  PubMed Central  Google Scholar 

  10. Nakazaki K, Yoshida M, Masamoto Y, Shinozaki-Ushiku A, Ikemura M, Hisamoto T, Yasunaga M, Sato S, Kurokawa M (2022) Discordant lymphomas of classic Hodgkin lymphoma and peripheral T-cell lymphoma following dupilumab treatment for atopic dermatitis. Int J Hematol 116(3):446–452. https://doi.org/10.1007/s12185-022-03330-y

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hematology, Medical Research Institute Kitano Hospital, PIIF Tazuke-kofukai, 2-4-20 Ohgimachi, Kita-ku, Osaka, 530-8480, Japan

    Mitsuhiro Shimada, Shojiro Inano & Toshiyuki Kitano

Authors
  1. Mitsuhiro Shimada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shojiro Inano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Toshiyuki Kitano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mitsuhiro Shimada.

Ethics declarations

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from the patient.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shimada, M., Inano, S. & Kitano, T. T-cell lymphoma associated with dupilumab. Ann Hematol 102, 1601–1602 (2023). https://doi.org/10.1007/s00277-023-05237-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-023-05237-y

Search

Navigation